Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr David Sheridan.

Newcastle AuthorsTitleYearFull text
Professor David Jones
Dr David Sheridan
A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis2022
Dr David Sheridan
Dr Simon Bridge
Dr Daniel Felmlee
Emeritus Professor Margaret Bassendine
Lipidomics analysis of fasting serum identifies novel lipid biomarkers specific for HCV genotype 3 and genotype 1 chronic hepatitis C virus infection2015
Dr Simon Bridge
Dr David Sheridan
Dr Daniel Felmlee
Fiona Fenwick
Dr Clare Lanyon
et al.		PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolism2015